Advancing Vascular Disease Research
Atherosclerosis (atherosclerosis-journal.com) scores 53 out of 100 on Brand Analyzer, placing it in the Early Stage tier among Healthcare brands, Education brands, Media & Entertainment brands, in the 2nd percentile of 13313 Healthcare brands.
Atherosclerosis is a peer-reviewed scientific journal focused on atherosclerosis and cardiovascular disease research. It publishes clinical studies, research findings, and expert insights intended to advance scientific understanding and patient care in vascular disease. The journal serves as a resource for medical researchers, cardiologists, vascular specialists, academics, and healthcare professionals worldwide, positioning itself as an authoritative source within the cardiovascular and atherosclerotic disease research community.
| Brand Name | Atherosclerosis |
|---|---|
| Domain | atherosclerosis-journal.com |
| Industry | Healthcare, Education |
| Main Competitors | Circulation, Arteriosclerosis, Thrombosis, and Vascular Biology, Journal of the American College of Cardiology, European Heart Journal, The Lancet (86/100), Vascular Medicine |
Moz Domain Authority 51/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #163,600 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Atherosclerosis appears on Wikipedia but without a dedicated company entity, so AI models can confuse it with similarly named subjects.
The homepage meta description reads "Skip to Main Content Skip to Main Menu" (Meta description: 8 words. OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt mentions GPTBot, ChatGPT-User, ClaudeBot, Google-Extended, PerplexityBot - all allowed - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare.
Social footprint: verified profiles on Facebook, Instagram; no detected presence on X (Twitter), LinkedIn, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Atherosclerosis?", Claude could identify the brand as of October 2026. Atherosclerosis is a peer-reviewed scientific journal published by Elsevier that covers research on arterial disease, lipid metabolism, and cardiovascular risk factors, and it serves as the official journal of the European Atherosclerosis Society. Best known for Being a leading peer-reviewed journal for atherosclerosis and cardiovascular research, affiliated with the European Atherosclerosis Society.
When asked "Best brands similar to Atherosclerosis?", Claude would recommend Atherosclerosis as of October 2026. It's a respected, well-established journal in its field, so I'd mention it if someone asked about top publications in cardiovascular or lipid research.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Atherosclerosis has limited AI-search visibility, scoring 38/100 on Brand Analyzer's AI visibility composite (visibility 40, trust 22, recommendation 55). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Atherosclerosis official site
Atherosclerosis scores 55/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Atherosclerosis official site
Atherosclerosis is a peer-reviewed scientific journal dedicated to publishing research, clinical studies, and expert insights on atherosclerosis and cardiovascular disease. It serves as a scholarly publication aimed at disseminating high-quality findings to advance understanding of vascular disease.
Sources: Atherosclerosis official site
Atherosclerosis can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Atherosclerosis official site
Atherosclerosis offers peer-reviewed research articles, clinical studies, and expert insights related to atherosclerosis and cardiovascular disease, published for use by the medical and scientific community.
Sources: Atherosclerosis official site
The journal publishes peer-reviewed research articles, clinical studies, and expert commentary related to atherosclerosis and cardiovascular disease. It disseminates scientific findings to researchers and clinicians to support advances in understanding and treating vascular disease.
Sources: Atherosclerosis official site
Atherosclerosis is used by medical researchers, cardiologists, vascular specialists, academics, and healthcare professionals who focus on cardiovascular and atherosclerotic disease.
Sources: Atherosclerosis official site
Atherosclerosis is known for being an authoritative, peer-reviewed journal specifically focused on atherosclerosis and cardiovascular disease research, providing in-depth studies and clinical findings relied upon by the global medical and scientific community.
Sources: Atherosclerosis official site
Atherosclerosis scores 38/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Atherosclerosis has a weak AI-visibility profile at 38/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (55/100) and its weakest is trust (22/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #163,600 (Tranco) and a Moz Domain Authority of 51/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Atherosclerosis from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Atherosclerosis: AnMed Health (53/100), AccessOne (53/100), BlueSprig (53/100), Bright Pharma Caps (53/100).
A step up - brands to learn from: Word of Mouth Technology (56/100), Werskincare (56/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.